STOCKS TRADE MIXED AS FOCUS TURNS TO U.S. INFLATION DATA

GameStop shares jump after retailer said it raked in US$1 billion from a recent share sale

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

7.68

+0.47

(+6.45%)

As of 10:46AM EDT. Market open.

Loading interactive chart...

Zacks
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
Zacks
Wall Street Analysts See a 69.15% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?
The consensus price target hints at a 69.2% upside potential for Fulcrum Therapeutics (FULC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.